000 | 01720 a2200457 4500 | ||
---|---|---|---|
005 | 20250513025122.0 | ||
264 | 0 | _c19810413 | |
008 | 198104s 0 0 eng d | ||
022 | _a0007-0920 | ||
024 | 7 |
_a10.1038/bjc.1980.305 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEl Kappany, H | |
245 | 0 | 0 |
_aThe antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery. _h[electronic resource] |
260 |
_bBritish journal of cancer _cNov 1980 |
||
300 |
_a703-11 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBCG Vaccine _xtherapeutic use |
650 | 0 | 4 |
_aBacterial Vaccines _xtherapeutic use |
650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
650 | 0 | 4 |
_aGlycolipids _xtherapeutic use |
650 | 0 | 4 |
_aLevamisole _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMaltose _xanalogs & derivatives |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xprevention & control |
650 | 0 | 4 |
_aNeoplasms, Experimental _xdrug therapy |
650 | 0 | 4 |
_aPalmitates _xtherapeutic use |
650 | 0 | 4 | _aPostoperative Period |
650 | 0 | 4 |
_aPropionibacterium acnes _ximmunology |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Strains |
700 | 1 | _aChopra, C | |
700 | 1 | _aNigam, V N | |
700 | 1 | _aBrailovsky, C A | |
700 | 1 | _aElhilali, M | |
773 | 0 |
_tBritish journal of cancer _gvol. 42 _gno. 5 _gp. 703-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.1980.305 _zAvailable from publisher's website |
999 |
_c7458685 _d7458685 |